- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Patient Satisfaction With Letter-Based Communication of LCS Pulmonary Nodule ResultsPatients were satisfied with receiving their lung cancer screening (LCS) pulmonary nodule results via letter and considered the amount of information provided in the letter appropriate.
Latest:
Impact of Patient-Reported Outcomes and Real-World Evidence in CLL and MCLPanelists discuss how patient-reported outcomes and real-world evidence influence clinical decision-making when selecting Bruton tyrosine kinase (BTK) inhibitors for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
Latest:
Harnessing AI for Population Health: A Call to Action for Policy Makers and Health Care LeadersThe authors detail how artificial intelligence could be used in primary, secondary, and tertiary prevention to improve health outcomes and provide better value-based care.
Latest:
Oncology Experts Spotlight Breakthrough Therapies, AI-Driven Care at PCOC 2025Oncology experts at PCOC 2025 discuss breakthrough therapies, AI-driven care, and evolving care delivery models shaping the future of oncology.
Latest:
A Cue-to-Action Pilot Project to Increase Screening MammographyA targeted cue-to-action campaign of outreach, education, and incentive can improve uptake of screening mammography.
Latest:
An Analysis of Medicare Accountable Care Organization Expense ReportsThe authors of this study examined expense reports to understand how participants in Medicare’s Accountable Care Organization Investment Model spent to achieve program goals.
Latest:
Aligning Incentives Could Increase Access to Lower-Cost Surgery Sites: Xiaoxi Zhao, PhDAligning patient and insurer incentives through price transparency, lower out-of-pocket costs, and broader networks could boost ASC use and access.
Latest:
Defining the Comprehensive Role of the Oncology Pharmacist in Multiple Myeloma: Marcus Flores, PharmD, BCPS, BCOPMarcus Flores, PharmD, BCPS, BCOP, discusses the vital role of pharmacists in multidisciplinary cancer care, exploring collaboration, patient-centered strategies, and AI.
Latest:
Enfortumab Vedotin With or Without Pembrolizumab Delivers Promising Responses for Upper Tract Urothelial CancerEnfortumab vedotin with or without pembrolizumab offers disease control benefits for patients with upper tract urothelial cancer, said Evangelia Vlachou, MD, of Johns Hopkins Medicine.
Latest:
Clinical Profile of COVID-19 Infection in Postvaccination IndividualsThis article describes the findings of an observational study carried out in India to examine the clinical profile of individuals detected to be COVID-19 positive post vaccination.
Latest:
Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney DiseasePatients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.
Latest:
Clinician-Identified Health Characteristics and Palliative Care Eligibility: Is Dementia Overlooked?Clinicians may underassess the need for community-based palliative care among patients with dementia.
Latest:
Association Between Screening for Suspected COVID-19 Cases and Outcomes of Patients Revisiting the Emergency DepartmentPatients who revisit the emergency department shortly after discharge are at high risk for complications and death, exacerbated by COVID-19 screening workload. Detection efforts impact outcomes.
Latest:
Dosing Schedules with Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma and Safety ConsiderationsRyan Haumschild, PharmD, MS, MBA, introduces the faculty and sets the agenda to explore disease background, novel therapies, and operational considerations in relapsed/refractory multiple myeloma.
Latest:
Primary Care Video and Telephone Telemedicine During the COVID-19 Pandemic: Treatment and Follow-up Health Care UtilizationTelephone visits may offer a simple and convenient option to address patient primary care needs without raising safety concerns.
Latest:
Addressing Cancer Care Challenges for Patients, and Ensuring Equity: Coral Omene, MD, PhDDelivering value-based cancer care requires overcoming hurdles to access care and tailoring care that prioritizes the quality-of-life metrics the patient values, explained Coral Omene, MD, PhD.
Latest:
It Take a Village in Cancer Care: A Q&A With David Nguyen, MDDavid Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Latest:
Linking Insured Adults to Behavioral Health Care: A Cost-Saving SolutionConnecting primary care providers and commercially insured adults to outpatient behavioral health services via a digital platform improved health outcomes and reduced medical costs.
Latest:
The “New” New Normal: Changes in Telemedicine Utilization Since COVID-19Telemedicine utilization has declined since the peak of the COVID-19 pandemic, but non–primary care specialties continue to see an increase in moderate- and high-complexity telemedicine visits.
Latest:
Concluding Remarks: Impact of Alzheimer Disease, Promising Treatments in Development, and Future OutlookLooking to the future of Alzheimer disease treatment, the panel discusses key takeaways on the evolving therapeutic landscape.
Latest:
Clinician's Role in Breast Cancer Care, Access: Lakshminarayanan Nandagopal, MDClinician's role in breast cancer care and access with reproductive and urinary oncologist Lakshminarayanan Nandagopal, MD
Latest:
People Experiencing Homelessness in Miami: Insurance Enrollment Rates, Hypertension TrendsPeople experiencing homelessness face significant barriers to health care access, leading to higher rates of hypertension even among those with health insurance.
Latest:
Eliminating Defects in Value: Turnaround of an MSSP ACOA health system transformational leadership framework and management system made visible and eliminated defects in value and was associated with reduced annual Medicare expenditures and increased quality between 2017 and 2020.
Latest:
Baloxavir vs Oseltamivir: Reduced Utilization and Costs in InfluenzaBaloxavir, compared with oseltamivir, was associated with lower health care resource utilization and costs in patients with influenza, particularly those at high risk of secondary complications.
Latest:
Differences in Savings and Quality by Type of ACO Model2016-2018 Next Generation Accountable Care Organization (ACO) and Medicare Shared Savings Program cost and quality data show similar performance, suggesting that increasing financial risk to health systems may not affect performance.
Latest:
Impact of Food Affordability on Diabetes-Related Preventable HospitalizationMedicaid enrollees residing in counties with greater food affordability had lower odds of preventable hospitalization related to diabetes.
Latest:
Integrated Care for Chronic Conditions: A Randomized Care Management TrialThe authors sought to understand the differential impact of payer-led community-based care management approaches on stakeholder-oriented outcomes for publicly insured adults with multiple chronic conditions.
Latest:
Experts Share Top Takeaways From AACR Annual Meeting 2025During interviews at the American Association for Cancer Research (AACR) Annual Meeting 2025, experts shared key insights from this year's conference.
